The receipt of this Import and Market permission paves way for the launch of Acalabrutinib 100mg capsules (Calquence) in India, subject to the receipt of related statutory approvals and licenses.
from India Infoline News Service https://ift.tt/33ey4yA
No comments:
Post a Comment